Thrombosis: Anticoagulant Rivaroxaban soon also available for children

Пресса/СМИ: другое

Период5 нояб. 2019

Материалы СМИ


Материалы СМИ

  • ЗаголовокThrombosis: Anticoagulant Rivaroxaban soon also available for children
    Степень признанияМеждународная
    Имя средства информации/СМИMedical Xpress
    Тип подачи информацииВеб
    Страна/TерриторияРоссийская Федерация
    Дата публикации05/11/2019
    ОписаниеMedicines can have different effects in children than in adults, which is not just a question of the right dose. Yet, still only few pharmaceuticals have been specifically tested and approved for this patient group. For treatment of thrombosis, children currently receive Heparin and Vitamin K antagonists which are problematic and not approved for children. A recent international study investigate the anticoagulant Rivaroxaban approved for adults in children with acute venous thromboembolism. Comparing the efficacy and safety of Rivaroxaban to standard treatment children showed positive results. The study was headed by the pediatrician Christoph Male from the Department of Paediatrics at the MedUni Vienna. The study was published in the journal Lancet Haematology.
    Производитель/авторMedical University of Vienna
    ПерсоныОльга Александровна Львова